correct.. and even if they offer 60% we are in a better position than with TEVA coz they will have a leading cardiovascular company on board. That's the way I see this unfolding. Let's wait and see.
Regarding CHF trial and MPC-150-IM, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $13.88M | 9.269M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 8894 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 7737 | 9 |
View Market Depth
| Last trade - 14.01pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |